欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号NL/V/0391/001
药品名称Lamoxsan 150 mg/ml suspension for injection for cattle and pigs
活性成分
    • amoxicillin trihydrate 150.0 mg/ml
剂型Suspension for injection
上市许可持有人Alfasan Nederland BV Kuipersweg 9 3449 JA Woerden The Netherlands
参考成员国 - 产品名称Netherlands (NL)
互认成员国 - 产品名称
    • Hungary (HU)
    • France (FR)
    • Bulgaria (BG)
    • Spain (ES)
    • Cyprus (CY)
    • Portugal (PT)
    • Czechia (CZ)
    • Italy (IT)
    • Romania (RO)
    • Greece (GR)
    • Slovakia (SK)
    • Sweden (SE)
    • Germany (DE)
    • Slovenia (SI)
    • Norway (NO)
    • Denmark (DK)
    • Croatia (HR)
    • Finland (FI)
    • Belgium (BE)
    • United Kingdom (Northern Ireland) (XI)
    • Poland (PL)
    • Luxembourg (LU)
    • Latvia (LV)
    • Iceland (IS)
    • Lithuania (LT)
    • Ireland (IE)
    • Estonia (EE)
    • Austria (AT)
许可日期2023/05/31
最近更新日期2023/11/01
药物ATC编码
    • QJ01CA04 amoxicillin
申请类型
  • TypeLevel1：food
  • TypeLevel2：Pharmaceutical
  • TypeLevel3：Generic - art 13.2 Dir 2001/82/EC
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase